WWTR1 and breast carcinoma: Bartucci and colleagues provide evidence that TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells, and TAZ expression level negatively correlates with shorter disease-free survival of breast cancer patients (Bartucci et al., 2015).